Zoflox, an Antibacterial Drug, in Treatment of Infectious Pathologic Processes in the Lower Respiratory Tract Complicating Acute Respiratory Viral Infection in Elderly Patients
Abstract
Clinical trial of Zoflox, an antimicrobial drug, was performed in complex therapy of elderly outpatients with acute pneumonia complicating acute respiratory viral infection. Among the outpatients there were elderly subjects with hepatic insufficiency. The drug showed to be efficient and safety when used in a middle therapeutic dose of 400 mg twice a day daily for 10-14 days.
About the Author
L. V. Zueva
Municipal Polyclinic No. 14; Municipal Polyclinic No. 2
Russian Federation
Russian Federation
References
1. Дворецкий Л.И., Яковлев С.В. Ошибки в антибактериальной терапии инфекций дыхательных путей в амбулаторной практике. Леч врач 2003; 8: 48-54.
2. Neuzil K. M., Reed G. W., Mitchel E. F., Griffin M. R. Influenza-associated morbidity and mortality in young and middle-aged women. JAMA 1999; 281: 901-907.
3. Чучалин А.Г., Цой А.Н., Архипов В.В. ир. Пневмония с точки зрения доказательной медицины. М.: 2000.
4. Management of Respiratory Tract Infections / Bartlett J. ed. 2001.
5. Дворецкий Л.И., Лазебник Л.Б., Яковлев С.В. Диагностика и лечение бактериальных инфекций у пожилых. М.: 1997.
6. Козлов С.Н., Рачина С.А., Домникова Н.П. Фармакоэпидемиологический анализ лечения внебольничной пневмонии в амбулаторных условиях. Клин микробиол антимикроб тер 2000; 2: 3: 74-81.
Review
For citations:
Zueva L.V. Zoflox, an Antibacterial Drug, in Treatment of Infectious Pathologic Processes in the Lower Respiratory Tract Complicating Acute Respiratory Viral Infection in Elderly Patients. Antibiot Khimioter = Antibiotics and Chemotherapy. 2012;57(9-10):32-37. (In Russ.)
Views:
298
Email this article 